Have a feature idea you'd love to see implemented?
Let us know!
NKTX Nkarta Inc
Price (delayed)
$2.44
Market cap
$172.19M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.88
Enterprise value
$197.93M
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with
Highlights
NKTX's EPS is up by 25% year-on-year and by 6% since the previous quarter
NKTX's debt is down by 4.5% year-on-year
Nkarta's equity has increased by 45% YoY but it has decreased by 4.9% QoQ
NKTX's quick ratio is down by 19% since the previous quarter but it is up by 17% year-on-year
Key stats
What are the main financial stats of NKTX
Market
Valuations
Earnings
Shares outstanding
70.57M
Market cap
$172.19M
Enterprise value
$197.93M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.4
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$110.61M
EBITDA
-$99.2M
Free cash flow
-$108.41M
Per share
Balance sheet
Liquidity
EPS
-$1.88
Free cash flow per share
-$1.47
Book value per share
$6.11
Revenue per share
$0
TBVPS
$7.23
Total assets
$532.03M
Total liabilities
$101.16M
Debt
$85.45M
Equity
$430.87M
Working capital
$267.68M
Debt to equity
0.2
Current ratio
12.91
Quick ratio
12.72
Net debt/EBITDA
-0.26
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-21.7%
Return on equity
-27.1%
Return on invested capital
-24.2%
Return on capital employed
-21.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NKTX stock price
How has the Nkarta stock price performed over time
Intraday
-2.4%
1 week
-9.63%
1 month
-42.18%
1 year
-3.56%
YTD
-63.03%
QTD
-46.02%
Financial performance
How have Nkarta's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$128.46M
Net income
-$110.61M
Gross margin
N/A
Net margin
N/A
Nkarta's net income has increased by 10% YoY but it has decreased by 2.5% QoQ
Nkarta's operating income has increased by 5% YoY but it has decreased by 3.6% from the previous quarter
Growth
What is Nkarta's growth rate over time
Valuation
What is Nkarta stock price valuation
P/E
N/A
P/B
0.4
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NKTX's EPS is up by 25% year-on-year and by 6% since the previous quarter
The P/B is 79% below the 5-year quarterly average of 1.9 and 60% below the last 4 quarters average of 1.0
Nkarta's equity has increased by 45% YoY but it has decreased by 4.9% QoQ
Efficiency
How efficient is Nkarta business performance
NKTX's return on equity is up by 26% year-on-year and by 6% since the previous quarter
The ROA has grown by 22% YoY and by 3.6% from the previous quarter
NKTX's return on invested capital is up by 8% year-on-year and by 3.2% since the previous quarter
Dividends
What is NKTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NKTX.
Financial health
How did Nkarta financials performed over time
NKTX's total assets is up by 31% YoY but it is down by 4% QoQ
The current ratio has contracted by 19% from the previous quarter but it has grown by 18% YoY
NKTX's debt is 80% smaller than its equity
Nkarta's equity has increased by 45% YoY but it has decreased by 4.9% QoQ
NKTX's debt to equity is down by 33% year-on-year but it is up by 5% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.